UK–based biotech company Procarta Biosystems has been funded by CARB-X to develop a new class of antibiotics to treat Gram-negative ESKAPE pathogens. CARB-X is awarding…
India has joined the Global AMR R&D Hub as a new Member. This expands the global partnership working to address challenges and improve international…
Swiss researchers from Zurich and Basel have discovered that resistance in intestinal bacteria can spread even if no antibiotic is used. Their results are…
WHO has published target product profiles for diagnostics against antibacterial resistance identified as priorities. Until 29th September a public consultation process is open. Based…
Erin Duffy, former CSO of US biotech company Melinta Therapeutics, replaces Karen Gallant as CARB-X‘s Chief of Research and Development. Erin Duffy will be…
To help guide the Global AMR R&D Hub’s collaborations a draft Collaboration Framework has been developed. Until 10th October, the consultation process is open.…
CARB-X has recently funded several vaccines projects to fight AMR-related infections developed by US-based SutroVax and Swiss Vaxxilon AG. In early September, CARB-X has…
The WHO has developed several draft target products profiles (TPPs) and is seeking feedback from AMR stakeholders until 29th September 2019. The global increase…